Paul N. Durrington
University of Manchester · 442 works · 37,877 citations · h-index 83
Top works
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary
- ESC/EAS Guidelines for the management of dyslipidaemias
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
- LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
- Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
- Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
- Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India
- APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE
- The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
- Paraoxonase and Atherosclerosis
- ESC/EAS Guidelines for the management of dyslipidaemias
- Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- HDL, its enzymes and its potential to influence lipid peroxidation
- Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel